On 23 February 2011 the Administrative Chamber of the “Audiencia Nacional” handed down an interesting judgment ordering the Administration to bear the damages caused by the erroneous price reduction of EVOPAD®, a medicament marketed by JANSSEN-CILAG comprised of Galantamine. The facts of the case may be summarised as follows: The Ministry of Health reduced by…

On 2 March 2011 the Barcelona Court of Appeal handed down a judgment reversing a decision from Commercial Court n.4 of Barcelona, which rejected the patent owners’ ‘lis pendens‘ defence against a revocation action filed by L.A. and others based on lack of inventive step. In its judgment of 2 March 2011, the Court of…

According to Article 79.3 of the 1986 Patents Act, patent rights not registered with the Patent Office may not be invoked against third parties. This article has sparked the debate as to whether a non-registered licensee may initiate patent infringement proceedings invoking a license agreement that has not yet been published. In its judgment dated…

On 30 June 2010, the Supreme Court held that the ‘Bolar provision’ introduced by Law 29/2006, which implemented Directive 2004/27 into Spanish law, may not be applied retrospectively. In addition, the Supreme Court revoked the view expressed by the Court of Appeal of Pamplona and other provincial Courts, which had considered that the ‘Bolar provision’…

On 3 August 2007 and 5 December 2007, Commercial Court Number 1 of Barcelona ordered a preliminary injunction preventing the launch of all the generics of a well-known medicament used to treat schizophrenia. Also, for the purpose of maintaining the status quo, the Court ordered for the judgment be notified to the Ministry of Health…